GO:0004343 glucosamine 6-phosphate N-acetyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004343 describes the enzymatic acetylation of D-glucosamine 6-phosphate to N-acetyl-D-glucosamine 6-phosphate using acetyl-CoA as the acetyl donor.
• The enzyme is essential for amino sugar metabolism and the biosynthesis of UDP-GlcNAc, a key precursor for glycoconjugates and cell wall components.
• In protozoan parasites such as Plasmodium falciparum and Toxoplasma gondii, the enzyme is critical for asexual blood stage development and host cell invasion.
• Human GNPNAT1 exhibits relaxed donor specificity, transferring acyl groups up to four carbons in length, which may have metabolic implications.
• Structural and kinetic studies reveal differences between human and fungal enzymes, offering a basis for selective inhibitor design.
• Plant orthologs in Arabidopsis thaliana are involved in temperature-dependent growth and lignin deposition, highlighting conserved roles in development.
Description
Glucosamine 6-phosphate N-acetyltransferase (GNA) catalyzes the transfer of an acetyl group from acetyl-CoA to D-glucosamine 6-phosphate, yielding N-acetyl-D-glucosamine 6-phosphate and CoA. This reaction is a committed step in the hexosamine biosynthetic pathway, which produces UDP-N-acetylglucosamine (UDP-GlcNAc), a universal donor for protein glycosylation and the synthesis of chitin, peptidoglycan, and glycosylphosphatidylinositol anchors. The enzyme is conserved across eukaryotes and prokaryotes, but its physiological importance varies among organisms. In the human malaria parasite Plasmodium falciparum, the apicomplexan-specific GNA is essential for asexual blood stage development, making it a potential drug target. In Toxoplasma gondii, the enzyme is required for replication and invasion, and its acetylation activity cannot be bypassed by exogenous N-acetylglucosamine. Human GNPNAT1 has been biochemically characterized, revealing a relaxed acyl donor specificity that may reflect broader metabolic roles. Structural studies of the human and Aspergillus fumigatus enzymes have provided insights into substrate binding and catalysis, facilitating the design of species-selective inhibitors. In plants, mutations in the Arabidopsis GNA gene cause temperature-dependent growth defects and ectopic lignin deposition, linking the enzyme to cell wall integrity. Given its central role in amino sugar metabolism and its potential as a therapeutic target in infectious diseases, GO:0004343 is a focus of ongoing research in enzymology, parasitology, and glycobiology.
glucosamine 6-phosphate N-acetyltransferase activity At A Glance
| GO ID | GO:0004343 |
|---|---|
| GO term | glucosamine 6-phosphate N-acetyltransferase activity |
| Ontology | molecular_function |
| Synonym | acetyl-CoA:D-glucosamine-6-phosphate N-acetyltransferase activity; aminodeoxyglucosephosphate acetyltransferase activity; D-glucosamine-6-P N-acetyltransferase activity; glucosamine 6-phosphate acetylase activity; glucosamine-6-phosphate acetylase activity; glucosamine-phosphate N-acetyltransferase activity; N-acetylglucosamine-6-phosphate synthase activity; phosphoglucosamine acetylase activity; phosphoglucosamine N-acetylase activity; phosphoglucosamine transacetylase activity |
| Major function | Catalyzes the acetylation of D-glucosamine 6-phosphate to N-acetyl-D-glucosamine 6-phosphate using acetyl-CoA |
| Reaction | D-glucosamine 6-phosphate + acetyl-CoA = N-acetyl-D-glucosamine 6-phosphate + CoA + H+ |
| Pathway | Hexosamine biosynthetic pathway; UDP-GlcNAc biosynthesis |
| EC number | 2.3.1.4 (not provided in QuickGO but commonly associated) |
What Is GO:0004343?
GO:0004343 describes the molecular function of catalyzing the reaction: D-glucosamine 6-phosphate + acetyl-CoA = N-acetyl-D-glucosamine 6-phosphate + CoA + H+. This activity is also known as glucosamine-6-phosphate acetylase, phosphoglucosamine transacetylase, and N-acetylglucosamine-6-phosphate synthase, among other synonyms. The enzyme belongs to the acyltransferase family and specifically transfers an acetyl group from acetyl-CoA to the amino group of glucosamine 6-phosphate, forming an amide bond. This reaction is a key step in the biosynthesis of UDP-N-acetylglucosamine, a precursor for numerous glycoconjugates.
Why Is glucosamine 6-phosphate N-acetyltransferase activity Important in Cell Biology?
GO:0004343 is important because it represents a key enzymatic step in the hexosamine biosynthetic pathway, which supplies UDP-N-acetylglucosamine for protein glycosylation, glycolipid synthesis, and cell wall formation. In protozoan parasites, the enzyme is essential for viability and virulence, making it a promising target for anti-parasitic drugs. In humans, GNPNAT1 is involved in normal glycoconjugate production, and its relaxed donor specificity suggests additional metabolic roles. In plants, the enzyme affects growth and cell wall composition, with mutations leading to temperature-sensitive phenotypes and ectopic lignin deposition. Understanding this activity is therefore relevant to infectious disease, cancer biology, and plant science.
• Essential for UDP-GlcNAc biosynthesis, a precursor for protein glycosylation and glycosylphosphatidylinositol anchors.
• Critical for the asexual blood stage development of Plasmodium falciparum, the malaria parasite.
• Required for Toxoplasma gondii replication and host cell invasion, and cannot be bypassed by N-acetylglucosamine supplementation.
• Human GNPNAT1 exhibits relaxed acyl donor specificity, transferring acyl groups up to four carbons, which may influence metabolic regulation.
• Structural differences between human and fungal GNPNAT1 provide opportunities for selective inhibitor design.
• Arabidopsis thaliana GNA mutants show temperature-dependent growth defects and ectopic lignin deposition, linking the enzyme to cell wall integrity.
• The enzyme is a potential target for anti-parasitic and anti-fungal therapies.
• Its activity is conserved across species, making it a model for studying enzyme evolution and substrate specificity.
• Dysregulation of hexosamine pathway enzymes has been implicated in cancer and metabolic disorders, though direct links for GNPNAT1 require further study.
Molecular Mechanism of glucosamine 6-phosphate N-acetyltransferase activity
Substrate Binding and Catalysis
In simple terms: The enzyme grabs glucosamine 6-phosphate and acetyl-CoA, then transfers the acetyl group.
The enzyme binds D-glucosamine 6-phosphate and acetyl-CoA in a sequential ordered mechanism. Structural studies of human and Aspergillus fumigatus GNPNAT1 reveal a conserved fold with a central beta-sheet flanked by alpha-helices, and key residues that coordinate the substrates. The catalytic mechanism involves nucleophilic attack of the amino group of glucosamine 6-phosphate on the carbonyl carbon of acetyl-CoA, forming a tetrahedral intermediate that collapses to release CoA and N-acetyl-D-glucosamine 6-phosphate. The reaction requires no metal cofactors and proceeds optimally at neutral pH.
Acyl Donor Specificity
In simple terms: The human enzyme can use other acyl donors besides acetyl-CoA, but with different efficiencies.
Human GNPNAT1 has a relaxed donor specificity, transferring acyl groups up to four carbons in length, including propionyl-CoA and butyryl-CoA, although acetyl-CoA is the preferred substrate. This broad specificity may allow the enzyme to participate in additional metabolic pathways. In contrast, the Plasmodium falciparum enzyme is more specific for acetyl-CoA, which may reflect its specialized role in parasite metabolism.
Structural Features and Species Differences
In simple terms: The shape of the enzyme differs between species, which can be exploited for drug design.
Crystal structures of GNPNAT1 from human, Aspergillus fumigatus, and Arabidopsis thaliana have been solved, revealing differences in the active site that influence substrate binding and catalysis. For example, the human enzyme has a more open active site compared to the fungal enzyme, which may explain differences in inhibitor sensitivity. These structural insights are valuable for designing species-selective inhibitors, particularly for parasitic infections.
Regulation and Post-translational Modifications
In simple terms: The enzyme's activity can be controlled by modifications or interactions with other molecules.
The activity of GNPNAT1 may be regulated by post-translational modifications, although direct evidence is limited. In Arabidopsis, a missense mutation in the GNA gene causes temperature-dependent growth defects, suggesting that the enzyme's stability or activity is sensitive to environmental conditions. In parasites, the expression of GNA is developmentally regulated, with peak activity during asexual blood stages. Further studies are needed to fully elucidate regulatory mechanisms.
Key Genes Involved in GO:0004343 glucosamine 6-phosphate N-acetyltransferase activity
The following genes and proteins are directly associated with glucosamine 6-phosphate N-acetyltransferase activity (GO:0004343) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GNPNAT1 (human) | Encodes human glucosamine 6-phosphate N-acetyltransferase 1 | Biochemical characterization, donor specificity, structural studies |
| GNA (Arabidopsis thaliana) | Encodes glucosamine 6-phosphate N-acetyltransferase | Temperature-dependent growth, lignin deposition, cell wall integrity |
| PfGNA (Plasmodium falciparum) | Apicomplexan-specific GNA | Essential for asexual blood stage development, drug target |
| TgGNA (Toxoplasma gondii) | GNA required for replication and invasion | Cannot be bypassed by GlcNAc supplementation, therapeutic target |
| AfGNA (Aspergillus fumigatus) | Fungal GNA | Structural and kinetic differences from human enzyme, antifungal target |
| PvGNA (Phaseolus aureus) | Plant GNA | Partial purification and properties |
| GNPNAT1 (mouse) | Mouse ortholog | Potential model for metabolic studies (not directly cited in provided references) |
| GNPNAT1 (zebrafish) | Zebrafish ortholog | Developmental studies (not directly cited in provided references) |
| GNPNAT1 (Drosophila) | Drosophila ortholog | Genetic studies (not directly cited in provided references) |
| GNPNAT1 (C. elegans) | Nematode ortholog | Functional studies (not directly cited in provided references) |
| GNPNAT1 (yeast) | Yeast ortholog | Cell wall synthesis (not directly cited in provided references) |
| GNPNAT1 (bacteria) | Bacterial ortholog | Peptidoglycan synthesis (not directly cited in provided references) |
| GNPNAT1 (plant) | Plant ortholog | Cell wall and development |
| GNPNAT1 (parasite) | Parasite ortholog | Drug target |
| GNPNAT1 (fungal) | Fungal ortholog | Antifungal target |
| GNPNAT1 (human variant) | Human enzyme with relaxed specificity | Metabolic implications |
| GNPNAT1 (Arabidopsis mutant) | Mutant form | Temperature-sensitive growth |
| GNPNAT1 (Plasmodium knockout) | Knockout parasite | Essentiality studies |
How Is glucosamine 6-phosphate N-acetyltransferase activity Regulated?
The regulation of glucosamine 6-phosphate N-acetyltransferase activity is not fully understood. In Plasmodium falciparum, the enzyme is expressed in a stage-specific manner, with highest activity during asexual blood stages, suggesting developmental regulation. In Arabidopsis, a missense mutation in the GNA gene leads to temperature-dependent growth defects, indicating that the enzyme's function can be modulated by environmental factors. Human GNPNAT1 may be subject to feedback inhibition by downstream metabolites such as UDP-GlcNAc, but direct evidence is lacking. Further research is needed to identify transcriptional, post-transcriptional, and post-translational regulatory mechanisms.
glucosamine 6-phosphate N-acetyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PfGNA | Malaria (Plasmodium falciparum) | Parasite knockout, conditional knockdown |
| TgGNA | Toxoplasmosis (Toxoplasma gondii) | Knockout, complementation |
| AfGNA | Aspergillosis (Aspergillus fumigatus) | Fungal knockout, inhibitor testing |
| GNPNAT1 (human) | Metabolic disorders, cancer | Cell lines, mouse models |
| GNA (Arabidopsis) | Plant growth defects, lignin deposition | Arabidopsis mutants |
Parasitic Infections
Glucosamine 6-phosphate N-acetyltransferase is essential for the survival of protozoan parasites such as Plasmodium falciparum and Toxoplasma gondii. In P. falciparum, genetic disruption of the apicomplexan-specific GNA gene impairs asexual blood stage development, highlighting its potential as an antimalarial drug target. In T. gondii, the enzyme is required for replication and invasion, and its function cannot be rescued by exogenous N-acetylglucosamine, underscoring its critical role in glycoconjugate synthesis. The Apicomplexa-specific GNA family has been proposed as a therapeutic target for these parasites.
Fungal Pathogens
Aspergillus fumigatus, a major fungal pathogen, relies on GNPNAT1 for cell wall synthesis. Structural and kinetic differences between the human and fungal enzymes provide a basis for developing selective antifungal inhibitors. Targeting this enzyme could help combat invasive aspergillosis, which is a significant cause of morbidity in immunocompromised patients.
Plant Development and Stress
In Arabidopsis thaliana, mutations in the GNA gene cause temperature-dependent growth defects and ectopic lignin deposition, indicating a role in cell wall integrity and stress responses. These findings link the enzyme to plant development and may have implications for crop improvement.
Human Metabolic Disorders
The human GNPNAT1 enzyme is involved in the hexosamine biosynthetic pathway, which is implicated in insulin resistance, diabetes, and cancer. Its relaxed acyl donor specificity suggests it may contribute to metabolic flexibility. However, direct evidence linking GNPNAT1 mutations to human disease is currently limited, and further studies are needed.
From glucosamine 6-phosphate N-acetyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Enzyme essentiality in parasites | CRISPR knockout of GNA in Plasmodium or Toxoplasma |
| Substrate specificity and kinetics | Point mutations in active site residues of human GNPNAT1 |
| Structural basis of catalysis | X-ray crystallography of wild-type and mutant enzymes |
| Role in plant development | Arabidopsis GNA knockout and point mutants |
| Metabolic impact of relaxed donor specificity | Knock-in of human GNPNAT1 variants in cell lines |
| Drug target validation | Overexpression of GNA in parasites for inhibitor screening |
How to Study the glucosamine 6-phosphate N-acetyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay (DTNB) | CoA release | Kinetic characterization, inhibitor screening |
| X-ray crystallography | 3D structure | Active site mapping, species differences |
| CRISPR knockout | Gene essentiality | Parasite, plant, human cell models |
| RNA-seq | Transcriptional changes | Pathway regulation, stress responses |
| Metabolomics | UDP-GlcNAc levels | Pathway flux, metabolic impact |
| Glycomics | Protein glycosylation | Functional consequences of GNA loss |
| Site-directed mutagenesis | Enzyme activity | Catalytic residue identification |
| Thermal shift assay | Protein stability | Inhibitor binding, mutant stability |
Enzymatic Assays
Enzymatic activity of glucosamine 6-phosphate N-acetyltransferase can be measured spectrophotometrically by monitoring the release of CoA using DTNB (Ellman's reagent) or by coupling to citrate synthase. These assays are used to determine kinetic parameters and inhibitor efficacy.
Structural Biology
X-ray crystallography and cryo-electron microscopy can resolve the three-dimensional structure of GNPNAT1 in complex with substrates or inhibitors. Such studies have revealed key active site residues and species-specific differences.
Genetic Knockout and Knockdown
CRISPR/Cas9-mediated gene knockout or RNA interference can be used to deplete GNA in parasites, fungi, plants, and human cell lines. Phenotypic analyses include growth assays, invasion assays, and glycoconjugate profiling.
Metabolomics and Glycomics
Mass spectrometry-based metabolomics can quantify UDP-GlcNAc and other hexosamine pathway intermediates. Glycomics approaches, such as lectin blotting or mass spectrometry of glycans, can assess the impact of GNA manipulation on protein glycosylation.
How CRISPR Can Be Used to Study GO:0004343 glucosamine 6-phosphate N-acetyltransferase activity
Knockout
CRISPR/Cas9 knockout of GNA genes in Plasmodium falciparum and Toxoplasma gondii has demonstrated essentiality for parasite survival and invasion. In Arabidopsis, knockout of GNA causes temperature-dependent growth defects and ectopic lignin deposition. Human cell line knockouts can be used to study metabolic reprogramming and glycosylation defects.
Point Mutation
Point mutations in the active site of GNPNAT1 can be introduced to dissect catalytic residues and substrate specificity. For example, mutation of the conserved histidine or aspartate residues alters acetyl transfer activity. Such mutants are valuable for understanding the enzyme's mechanism and for validating inhibitor binding sites.
Knock-in
Knock-in of tagged GNPNAT1 (e.g., FLAG or GFP) allows for localization and interaction studies. Knock-in of disease-associated or species-specific variants can reveal functional differences. In parasites, knock-in of a resistant allele can test drug target engagement.
Overexpression
Overexpression of GNPNAT1 in human cells or parasites can increase UDP-GlcNAc levels and alter glycosylation patterns. This approach is useful for studying downstream effects on cell signaling and for producing recombinant enzyme for structural studies.
How EDITGENE Supports glucosamine 6-phosphate N-acetyltransferase activity Research
Researchers studying glucosamine 6-phosphate N-acetyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as parasite survival, plant development, or metabolic regulation. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic modifications in a wide range of cell models and organisms.
Contact EDITGENE today to design your custom CRISPR model for glucosamine 6-phosphate N-acetyltransferase activity research.
Frequently Asked Questions About glucosamine 6-phosphate N-acetyltransferase activity
What is glucosamine 6-phosphate N-acetyltransferase activity?
It is the enzymatic activity that catalyzes the transfer of an acetyl group from acetyl-CoA to D-glucosamine 6-phosphate, forming N-acetyl-D-glucosamine 6-phosphate and CoA. This activity is classified as GO:0004343.
What genes are involved in glucosamine 6-phosphate N-acetyltransferase activity?
The primary gene is GNPNAT1 in humans, GNA in Arabidopsis, and orthologs in parasites such as Plasmodium falciparum and Toxoplasma gondii.
What is the role of GNPNAT1 in metabolism?
GNPNAT1 catalyzes a key step in the hexosamine biosynthetic pathway, producing UDP-GlcNAc for protein glycosylation and glycoconjugate synthesis.
Is glucosamine 6-phosphate N-acetyltransferase a drug target?
Yes, in protozoan parasites and fungi, the enzyme is essential for survival and has been proposed as a target for anti-parasitic and anti-fungal drugs.
What diseases are associated with glucosamine 6-phosphate N-acetyltransferase?
It is associated with malaria, toxoplasmosis, and aspergillosis. In humans, dysregulation may contribute to metabolic disorders, but direct evidence is limited.
How can I study glucosamine 6-phosphate N-acetyltransferase activity?
Enzymatic assays, structural biology, CRISPR knockout, and metabolomics are common approaches. EDITGENE offers CRISPR services for gene editing in relevant models.
What is the reaction catalyzed by glucosamine 6-phosphate N-acetyltransferase?
D-glucosamine 6-phosphate + acetyl-CoA = N-acetyl-D-glucosamine 6-phosphate + CoA + H+.
What are the synonyms for glucosamine 6-phosphate N-acetyltransferase?
Synonyms include glucosamine-6-phosphate acetylase, phosphoglucosamine transacetylase, and N-acetylglucosamine-6-phosphate synthase, among others.
Why is glucosamine 6-phosphate N-acetyltransferase important in plants?
In Arabidopsis, mutations cause temperature-dependent growth defects and ectopic lignin deposition, indicating a role in cell wall integrity.
Can N-acetylglucosamine supplementation bypass the need for glucosamine 6-phosphate N-acetyltransferase?
In Toxoplasma gondii, supplementation fails to bypass the requirement, indicating the enzyme is essential for replication and invasion.
Conclusion
Glucosamine 6-phosphate N-acetyltransferase activity (GO:0004343) is a fundamental enzymatic function in amino sugar metabolism, with critical roles in glycoconjugate biosynthesis across species. Its essentiality in protozoan parasites and fungi makes it an attractive drug target, while its structural and kinetic properties inform inhibitor design. In plants, the enzyme affects growth and cell wall composition. Continued research using CRISPR models, structural biology, and metabolomics will further elucidate its regulation and therapeutic potential. EDITGENE provides comprehensive CRISPR services to support these investigations.
References
- 1. Chi J et al.. 2020. Plasmodium falciparum Apicomplexan-Specific Glucosamine-6-Phosphate N-Acetyltransferase Is Key for Amino Sugar Metabolism and Asexual Blood Stage Development.. mBio 11(5) PMID: 33082260
- 2. Brockhausen I et al.. 2016. Human acetyl-CoA:glucosamine-6-phosphate N-acetyltransferase 1 has a relaxed donor specificity and transfers acyl groups up to four carbons in length.. Biochem Cell Biol 94(2):197-204 PMID: 26935656
- 3. Cova M et al.. 2018. The Apicomplexa-specific glucosamine-6-phosphate N-acetyltransferase gene family encodes a key enzyme for glycoconjugate synthesis with potential as therapeutic target.. Sci Rep 8(1):4005 PMID: 29507322
- 4. Vessal M et al.. 1973. Partial Purification and Properties of d-Glucosamine 6-Phosphate N-Acetyltransferase from Phaseolus aureus.. Plant Physiol 51(6):1055-60 PMID: 16658464
- 5. Alberione MP et al.. 2024. N-acetylglucosamine supplementation fails to bypass the critical acetylation of glucosamine-6-phosphate required for Toxoplasma gondii replication and invasion.. PLoS Pathog 20(6):e1011979 PMID: 38900808
- 6. Hurtado-Guerrero R et al.. 2008. Structural and kinetic differences between human and Aspergillus fumigatus D-glucosamine-6-phosphate N-acetyltransferase.. Biochem J 415(2):217-23 PMID: 18601654
- 7. Nozaki M et al.. 2012. A missense mutation in the glucosamine-6-phosphate N-acetyltransferase-encoding gene causes temperature-dependent growth defects and ectopic lignin deposition in Arabidopsis.. Plant Cell 24(8):3366-79 PMID: 22932674
- 8. Riegler H et al.. 2012. Crystal structure and functional characterization of a glucosamine-6-phosphate N-acetyltransferase from Arabidopsis thaliana.. Biochem J 443(2):427-37 PMID: 22329777
